VEGFA and breast cancer: In addition to the previously described data linking circulating VEGF levels to patient outcomes in breast cancer (26, 27, 44), recent transcriptomic studies have directly linked increased expression of many pro-angiogenic genes with poor patient outcomes (44, 45).